Charlotte Gimpel

ORCID: 0000-0003-1296-9081
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and related cancers
  • Genetic and Kidney Cyst Diseases
  • Renal Diseases and Glomerulopathies
  • Pediatric Urology and Nephrology Studies
  • Blood Pressure and Hypertension Studies
  • Vasculitis and related conditions
  • Dialysis and Renal Disease Management
  • Gastroesophageal reflux and treatments
  • Congenital Heart Disease Studies
  • Pharmaceutical studies and practices
  • Coronary Artery Anomalies
  • Cardiovascular Function and Risk Factors
  • Renal cell carcinoma treatment
  • Neonatal Health and Biochemistry
  • Chronic Kidney Disease and Diabetes
  • Renal function and acid-base balance
  • Nephrotoxicity and Medicinal Plants
  • Cancer, Hypoxia, and Metabolism
  • Cardiovascular Syncope and Autonomic Disorders
  • Celiac Disease Research and Management
  • Autoimmune and Inflammatory Disorders Research
  • Immune Cell Function and Interaction
  • Retinopathy of Prematurity Studies
  • Williams Syndrome Research
  • Ion Transport and Channel Regulation

German Center for Pediatric and Adolescent Rheumatology
2025

University Hospital Heidelberg
2009-2025

Heidelberg University
2009-2025

University Hospital Münster
2024

University Medical Center Freiburg
2014-2023

Klinikum Konstanz
2021-2023

University of Freiburg
2016-2022

Center for HIV and Hepatogastroenterology
2021

Zentrum für Kinderheilkunde
2019

Klinik und Poliklinik für Kinder- und Jugendmedizin
2014

Kidney cysts can manifest as focal disease (simple and complex kidney cysts), affect a whole (eg, multicystic dysplastic or cystic dysplasia), bilateral autosomal recessive polycystic [ARPKD] dominant [ADPKD]). In children, opposed to adults, larger proportion of are due genetic diseases HNF1B nephropathy, various ciliopathies, tuberous sclerosis complex), fewer patients have simple acquired disease. The purpose this consensus statement is provide clinical guidance on standardization imaging...

10.1148/radiol.2018181243 article EN Radiology 2019-01-01
Karolis Ažukaitis Wenjun Ju Marietta Kirchner Viji Nair Michelle R. Smith and 95 more Zhiyin Fang Daniela Thurn‐Valsassina Aysun Karabay Bayazıt Anna Niemirska Nur Canpolat İpek Kaplan Bulut Fatoş Yalçınkaya Dušan Paripović Jérôme Harambat Nilgün Çakar Harika Alpay Francesca Lugani Francesca Mencarelli Mahmut Çivilibal Hakan Erdoğan Jutta Gellermann Enrico Vidal Yılmaz Tabel Charlotte Gimpel Pelin Ertan Önder Yavaşcan Anette Melk Uwe Querfeld Elke Wühl Matthias Kretzler Franz Schaefer Klaus Arbeiter Alejandra Rosales Ladislav Dušek Ariane Zaloszyc Uwe Querfeld Jutta Gellermann Max C. Liebau Lutz T. Weber Evelin Muschiol Rainer Büscher Jun Oh Anette Melk Daniela Thurn-Valassina Dieter Haffner Franz Schaefer Charlotte Gimpel Ulrike John Simone Wygoda Nikola Jeck Marianne Wigger Sara Testa Luisa Murer Chiara Matteucci Augustina Jankauskienė Karolis Ažukaitis Dorota Drożdż Francesca Lugani Aleksandra Żurowska Marcin Zaniew Mieczysław Litwin Anna Nimierska Ana Teixeira Amira Peco‐Antić Dušan Paripović Guido F. Laube Ali Anarat Aysun Karabay Bayazıt Ali Düzova Yelda Bilginer Salim Çalışkan Nur Canpolat Mahmut Çivilibal Sevgı Mır Betül Sözeri Brigitta Kranz Francesca Mencarelli Barry C. Dorn Fatoş Yalçınkaya Esra Baskın Nilgün Çakar Oğuz Söylemezoğlu Sevinç Emre Cengiz Candan Aysel Kıyak Gül Özçelik Harika Alpay Rukshana Shroff Bruno Rachin Jérôme Harambat Maria Szczepańska Hakan Erdoğan Osman Dönmez Ayşe Balat Nejat Aksu Yılmaz Tabel Pelin Ertan Ebru Yılmaz Ali Anarat Ayşı̇n Bakkaloğlu

10.1016/j.kint.2019.01.035 article EN publisher-specific-oa Kidney International 2019-03-20

Few antihypertensive drugs are available in appropriate formulations for infants.We investigated candesartan cilexetil liquid suspension a 4-week, randomized double-blind dose-ranging study followed by 1-year open-label treatment phase (NCT00244621). The drug was administered at 0.05, 0.2 or 0.4 mg/kg per day 93 hypertensive children aged 1-5 years, of whom 74 had underlying renal disorders.A single-dose pharmacokinetic profile obtained 10 patients. At 4 weeks, SBP declined dose dependently...

10.1097/hjh.0b013e328336b86b article EN Journal of Hypertension 2010-03-23

The Wilms' tumor suppressor WT1 is a key regulator of podocyte function that mutated in Denys-Drash and Frasier syndromes. Here we have used an integrative approach employing ChIP, exon array, genetic analyses mice to address general isoform-specific functions differentiation. Analysis ChIP-Seq data showed almost half the podocyte-specific genes are direct targets WT1. Bioinformatic analysis further identified coactivator FOXC1-binding sites proximity WT1-bound regions, thus supporting...

10.1038/ki.2015.140 article EN publisher-specific-oa Kidney International 2015-05-20

The introduction of digital pathology to nephrology provides a platform for the development new methodologies and protocols visual, morphometric computer-aided assessment renal biopsies. Application imaging made substantial progress over past decade; it is now in use education, clinical trials translational research. Digital evolved as valuable tool generate comprehensive structural information form, key prerequisite achieving precision computational biology. application this technology on...

10.1093/ckj/sfw129 article EN cc-by-nc Clinical Kidney Journal 2016-11-16

10.1016/j.kint.2025.02.026 article EN Kidney International 2025-03-01

The objective of this study was to determine which the many risk factors for nephrocalcinosis (NC) in preterm infants are most relevant.In 55 neonates born before 32 completed weeks gestation, parameters relevant NC were analyzed. Median birthweight 1010 g (range 500-2070 g). Fifteen (27%) asymptomatic children had ultrasonographic NC.In multivariate analysis strongest independent factor furosemide therapy above 10 mg per kg bodyweight cumulative dose, with a 48-fold increased (odds ratio...

10.1111/j.1442-200x.2009.02886.x article EN Pediatrics International 2009-05-18

Background Casual office blood pressure (CBP) measurements are still standard in antihypertensive drug trials. In pediatric hypertensive trials, ethical considerations, very low disease prevalence and the marked impact of white-coat hypertension create need for sensitive reproducible techniques BP assessment. We hypothesized that ambulatory monitoring (ABPM) may identify treatment effects more sensitively than CBP thereby reduce sample sizes required Methods Standard deviations (SDs) were...

10.1097/hjh.0b013e32832cb2a8 article EN Journal of Hypertension 2009-07-21

The uremic toxins indoxyl sulfate (IS) and p-cresyl (pCS) accumulate in patients with chronic kidney disease (CKD) as a consequence of altered gut microbiota metabolism decline renal excretion. Despite solid experimental evidence for nephrotoxic effects, the impact on progression CKD has not been investigated representative patient cohorts. In this analysis, IS pCS serum concentrations were measured 604 pediatric participants (mean eGFR 27 ± 11 ml/min/1.73m2) at enrolment into prospective...

10.1371/journal.pone.0240446 article EN cc-by PLoS ONE 2020-10-27
Christian Lerch Rukshana Shroff Mandy Wan Lesley Rees Helen Aitkenhead and 95 more İpek Kaplan Bulut Daniela Thurn Aysun Karabay Bayazıt Anna Niemirska Nur Canpolat Ali Düzova Karolis Ažukaitis Ebru Yılmaz Fatoş Yalçınkaya Jérôme Harambat Aysel Kıyak Harika Alpay Sandra Habbig Ariane Zaloszyc Oğuz Söylemezoğlu Cengiz Candan Alejandra Rosales Anette Melk Uwe Querfeld Maren Leifheit‐Nestler Anja Sander Franz Schaefer Dieter Haffner Gérard Cortina Klaus Arbeiter Ladislav Dušek Jérôme Harambat Bruno Ranchin Michel Fischbach A. Zalosczyk Uwe Querfeld Sandra Habbig Marc Galiano Rainer Büscher Charlotte Gimpel Markus J. Kemper Anette Melk Daniela Thurn Franz Schaefer Anke Doyon Elke Wühl Michael Pohl Simone Wygoda N Jeck Birgitta Kranz Marianne Wigger Giovanni Montini Francesca Lugani Sara Testa Enrico Vidal Maria Chiara Matteucci Stefano Picca Augustina Jankauskienė Karolis Ažukaitis Aleksandra Żurowska D. Drodz Marcin Tkaczyk Tomasz Urasiński Mieczysław Litwin Anna Niemirska Maria Szczepańska Ayla Josma Texeira A Peco-Antić B. Bucher Guido F. Laube Ali Anarat Aysun Karabay Bayazıt Fatoş Yalçınkaya E. Basin Nilgün Çakar Oğuz Söylemezoğlu Ali Düzova Yelda Bilginer Hakan Erdoğan Osman Dönmez Ayşe Balat Aysel Kıyak Salim Çalışkan Nur Canpolat Cengiz Candan Mahmut Çivilibal Sevinç Emre Harika Alpay Gül Özçelik S. Mir Betül Sözeri Önder Yavaşcan Yılmaz Tabel P Ertan Engin Yılmaz Rukshana Shroff Agnieszka Prytula-Ebels Justine Bachetta Dieter Haffner Günter Klaus

We investigated the effects of nutritional vitamin D supplementation on markers bone and mineral metabolism, i.e. serum levels fibroblast growth factor 23 (FGF23), Klotho, alkaline phosphatase (BAP) sclerostin, in two cohorts with chronic kidney disease (CKD).In all, 80 D-deficient children were selected: 40 mild to moderate CKD from ERGO study, a randomized trial ergocalciferol [estimated glomerular filtration rate (eGFR) 55 mL/min/1.73 m2], advanced observational Cardiovascular Comorbidity...

10.1093/ndt/gfy012 article EN Nephrology Dialysis Transplantation 2018-01-12

IntroductionNephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% end-stage kidney disease (ESKD) in children. Prediction prognosis poses major challenge. We assessed differences survival, impact variant type, and the association clinical characteristics with declining function.MethodsData was obtained from 3 independent sources, namely network early onset cystic diseases registry (n = 105), an online survey sent out European Reference Network Rare Kidney...

10.1016/j.ekir.2022.05.035 article EN cc-by-nc-nd Kidney International Reports 2022-06-16

Purpose.: To prospectively study plasma levels of soluble E-selectin (sE-selectin) in premature infants and to identify their relationship retinopathy prematurity (ROP) on the background known clinical risk factors. Methods.: Eighty-five sE-selectin samples from 42 preterm born at 23 32 weeks gestational age (GA) were analyzed. Twenty-two did not have ROP, eight had stage I, seven II, five III. Infants having no ROP or I designated as no-ROP group, with II III formed group. Results.: In...

10.1167/iovs.09-4723 article EN Investigative Ophthalmology & Visual Science 2010-03-19

The choice and timing of kidney replacement therapy (KRT) is influenced by clinical factors, laboratory features, feasibility issues, family preferences, clinicians' attitudes. We analyzed the factors associated with KRT modality in a multicenter, multinational prospective pediatric cohort study.

10.1016/j.ekir.2024.06.009 article EN cc-by Kidney International Reports 2024-06-12

Nephronophthisis (NPH) comprises a heterogeneous group of inherited renal ciliopathies clinically characterized by progressive kidney failure. So far, definite diagnosis is based on molecular testing only. Here, we studied the feasibility NPHP1 and NPHP4 immunostaining nasal epithelial cells to secure accelerate NPH.

10.1007/s00467-024-06443-0 article EN cc-by Pediatric Nephrology 2024-08-05

Abstract Background Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening microangiopathy, frequently causing kidney failure. Inhibition of the terminal complement complex with eculizumab only licensed treatment but mostly requires long-term administration and risks severe side effects. The underlying genetic cause aHUS thought to influence severity initial recurring episodes, milder courses in patients mutations membrane cofactor protein ( MCP ). Methods Twenty pediatric...

10.1007/s00467-020-04714-0 article EN cc-by Pediatric Nephrology 2020-07-26
Coming Soon ...